Charles M Baum's Net Worth

$41.1 Million

Estimate Recalculated Nov 11, 2024 08:35AM EST

Who is Charles M Baum?

Charles M Baum has an estimated net worth of $41.1 Million. This is based on reported shares across multiple companies, which include IMMUNOMEDICS INC, PMV Pharmaceuticals, Inc., Mirati Therapeutics, Inc., BCTG Acquisition Corp., Poseida Therapeutics, Inc., ARRAY BIOPHARMA INC, and Acrivon Therapeutics, Inc..

SEC CIK

Charles M Baum's CIK is 0001579824

Past Insider Trading and Trends

2019 was Charles M Baum's most active year for acquiring shares with 13 total transactions. Charles M Baum's most active month to acquire stocks was the month of May. 2019 was Charles M Baum's most active year for disposing of shares, totalling 25 transactions. Charles M Baum's most active month to dispose stocks was the month of November. 2023 saw Charles M Baum paying a total of $3,199,966.75 for 187,443 shares, this is the most they've acquired in one year. In 2022 Charles M Baum cashed out on 157,938 shares for a total of $8,204,176.80, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

IMMUNOMEDICS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-9.67K
—
—
0
Oct 23
Form 4
+38.46%
3.72K
—
—
13.38K
Jun 18
Form 4
∞
9.67K
—
—
9.67K
Jun 7
Form 4
—
0
—
—
0
Feb 23
Form 3
—
0
—
—
0
No matching records found

PMV Pharmaceuticals, Inc. (PMVP) Snapshot price: $1.6588

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 2
Form 4
—
0
—
—
0
Jun 2
Form 4
—
0
—
—
0
Apr 5
Form 3
—
0
—
—
0
No matching records found

Mirati Therapeutics, Inc. (MRTX) No price found

Founder, President, and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-237.87K
—
—
0
Jan 23
Form 4
+8.99%
20.43K
$58.75
$1,199,968.75
247.7K
Dec 29
Form 4
+31.21%
54.05K
$37.00
$1,999,998.00
227.28K
Aug 9
Form 4
+2.63%
4.44K
—
—
173.22K
Jan 20
Form 4
-2.12%
-3.65K
$46.60
-$169,996.80
168.78K
Jan 4
Form 4
+34.81%
44.53K
$40.42
-$367,468.64
172.43K
Dec 19 - Dec 21
Form 4
—
0
$58.71
-$5,719,853.04
127.9K
Scheduled
Nov 28
Form 4
+26.42%
26.73K
$73.74
-$203,272.45
127.9K
Jan 14 - Jan 18
Form 4
-3.91%
-4.11K
$147.75
-$607,854.71
101.17K
Jan 4
Form 4
-6.59%
-7.43K
—
—
105.28K
Dec 16
Form 4
—
0
$70.85
-$5,886,925.50
112.71K
Scheduled
Dec 3
Form 4
—
0
$86.98
-$6,278,632.60
112.71K
Scheduled
Jun 18
Form 4
+2.08%
2.29K
$5.40
$12,376.80
112.71K
Jan 26
Form 4
+26.18%
22.91K
$27.00
$87,615.00
110.42K
Jan 15 - Jan 19
Form 4
-4.90%
-4.51K
$210.39
-$949,066.22
87.51K
Jan 6
Form 4
-9.80%
-10.00K
—
—
92.02K
Dec 29
Form 4
—
0
$121.49
-$9,039,513.57
102.02K
Scheduled
Dec 18
Form 4
-4.67%
-5.00K
—
—
102.02K
Jul 23
Form 4
+0.52%
557
$5.40
$3,007.80
107.02K
Apr 27
Form 4
—
0
$49.41
-$3,273,508.77
106.47K
Scheduled
Apr 17
Form 4
+2.20%
2.29K
$5.40
$12,371.40
106.47K
Mar 27
Form 4
+2.25%
2.29K
$5.40
$12,371.40
104.17K
Feb 28
Form 4
+4.82%
4.69K
$15.41
$72,247.44
101.88K
Feb 4
Form 4
+69.93%
40K
—
—
97.2K
Jan 3
Form 4
+0.56%
318
$24.93
$7,927.23
56.92K
Dec 24
Form 4
-15.02%
-10.00K
—
—
56.6K
Dec 19
Form 4
+0.84%
558
$47.45
-$4,013,021.44
66.6K
Scheduled
Aug 22
Form 4
—
0
$42.09
-$3,480,286.61
66.04K
Scheduled
Feb 25
Form 4
+5.80%
3.62K
$21.58
$78,173.43
66.04K
Feb 21
Form 4
—
0
—
—
0
Jan 17
Form 4
+22.55%
11.49K
$33.84
-$2,341,432.14
62.42K
Scheduled
Aug 23 - Aug 24
Form 4
—
0
$18.37
-$1,012,072.75
110.55K
Scheduled
Feb 23
Form 4
—
0
—
—
0
Jan 18
Form 4
—
0
—
—
0
May 9
Form 4
—
0
—
—
0
Jan 26
Form 4
+70.04%
20K
$7.05
$141,070.00
48.56K
Jun 14
Form 4
—
0
—
—
0
Jan 22
Form 4
—
0
—
—
0
Feb 4
Form 4
+70.20%
11.78K
$8.49
$99,995.22
28.56K
Jul 25
Form 4
—
0
—
—
0
May 21
Form 4
+235.56%
11.78K
$8.49
$99,995.22
16.78K
Feb 19
Form 4
∞
5K
$16.96
$84,819.00
5K
Nov 26
Form 4
—
0
—
—
0
Jul 17
Form 3
—
0
—
—
0
No matching records found

BCTG Acquisition Corp. (TNGX) Snapshot price: $10.89

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Poseida Therapeutics, Inc. (PSTX) Snapshot price: $2.74

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+33.33%
19.65K
—
—
78.6K
Jun 17
Form 4
+50.00%
19.65K
—
—
58.95K
Jun 15
Form 4
∞
39.3K
—
—
39.3K
Jun 16
Form 3
—
0
—
—
0
No matching records found